Evidence map›Paper›PMID 38535591›Full record

ArticlePathogens (Basel, Switzerland)2024

Antifungal Susceptibility of

Aleksandra Górzyńska, Kamila Kondracka, Agnieszka Korzeniowska-Kowal, Urszula Nawrot

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Antifungal Susceptibility of ClinicalPathogens (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Phylogenomic diversity of clinicalMicrobiology spectrum · 2026
    Article
  7. Article
  8. Article
  9. Synthesis and Biological Activity of Ultrashort Antimicrobial Peptides Bearing a Non-Coded Amino Acid.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aleksandra GórzyńskaDepartment of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Kamila KondrackaDepartment of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Agnieszka Korzeniowska-KowalDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, St. Weigla 12, 53-114 Wroclaw, Poland.
Urszula NawrotDepartment of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-0906-2377
Wroclaw Medical University · PLLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PL

Funding

Wroclaw Medical University SUBZ.D230.24.001
6 · The paper itself

Abstract

(1) Background: Despite being considered a non-pathogenic yeast, recently, a growing occurrence of

Indexed as

Amphotericin BAntifungal AgentsMicrobial Sensitivity TestsSaccharomyces cerevisiaeCaspofunginDrug Resistance, FungalEchinocandinsFluconazoleFlucytosineHumansItraconazoleMycosesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTriazolesVoriconazoleAmphotericin BAntifungal AgentsCaspofunginEchinocandinsFluconazoleFlucytosineItraconazoleposaconazoleTriazolesVoriconazoleamphotericin BazolesechinocandinsflucytosinemanogepixSaccharomyces cerevisiae

Identifiers

PMID38535591
PMCPMC10974509
OpenAlexW4392817281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.